Healthy volunteers test new drug solrikitug in Early-Stage safety trial
NCT ID NCT06868082
First seen Jan 17, 2026 · Last updated May 18, 2026 · Updated 14 times
Summary
This early-stage study tested the safety and how the body processes two forms of the experimental drug solrikitug in 32 healthy adults, both Japanese and non-Japanese. Participants received the drug under the skin and were monitored for side effects and drug levels. Since this study involved healthy people, it was not designed to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Brisbane, Queensland, Australia
Conditions
Explore the condition pages connected to this study.